相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dual mTORC1/mTORC2 inhibition diminishes Akt activation and induces Puma-dependent apoptosis in lymphoid malignancies
Mamta Gupta et al.
BLOOD (2012)
Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma
Robert Kridel et al.
BLOOD (2012)
Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma
John P. Leonard et al.
BLOOD (2012)
Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma
Lina Nygren et al.
BLOOD (2012)
Behind the scenes of non-nodal MCL: downmodulation of genes involved in actin cytoskeleton organization, cell projection, cell adhesion, tumour invasion, TP53 pathway and mutated status of immunoglobulin heavy chain genes
Ilaria Del Giudice et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Molecular Subsets of Mantle Cell Lymphoma Defined by the IGHV Mutational Status and SOX11 Expression Have Distinct Biologic and Clinical Features
Alba Navarro et al.
CANCER RESEARCH (2012)
Molecular Pathways: Targeting Proteasomal Protein Degradation in Cancer
Susan M. Molineaux
CLINICAL CANCER RESEARCH (2012)
In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior
Alejandra Carvajal-Cuenca et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
The impact of cyclin D1 mRNA isoforms, morphology and p53 in mantle cell lymphoma: p53 alterations and blastoid morphology are strong predictors of a high proliferation index
Julia Slotta-Huspenina et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma
Christoph Renner et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Inhibition of poly(ADP-ribose) polymerase (PARP) and ataxia telangiectasia mutated (ATM) on the chemosensitivity of mantle cell lymphoma to agents that induce DNA strand breaks
Radha M. Golla et al.
HEMATOLOGICAL ONCOLOGY (2012)
ChIP sequencing of cyclin D1 reveals a transcriptional role in chromosomal instability in mice
Mathew C. Casimiro et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
The miRNA-17∼92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation
E. Rao et al.
LEUKEMIA (2012)
Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease
C. Royo et al.
LEUKEMIA (2012)
Proteasome Inhibition and Combination Therapy for Non-Hodgkin's Lymphoma: From Bench to Bedside
Anthony R. Mato et al.
ONCOLOGIST (2012)
Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation
Patricia Perez-Galan et al.
BLOOD (2011)
Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases
Anastasia Hadzidimitriou et al.
BLOOD (2011)
Enzastaurin hydrochloride for lymphoma: reassessing the results of clinical trials in light of recent advances in the biology of B-cell malignancies
Loic Ysebaert et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
Should there be a standard therapy for mantle cell lymphoma?
Mitchell R. Smith
FUTURE ONCOLOGY (2011)
Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis
Sarah L. Ondrejka et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Indolent Mantle-Cell Lymphoma: Immunoglobulin Variable Region Heavy Chain Sequence Analysis Reveals Evidence of Disease 10 Years Prior to Symptomatic Clinical Presentation
Simon A. J. Rule et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Phase II Study of Vorinostat for Treatment of Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma
Mark Kirschbaum et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation
Giulia Fabbri et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Temsirolimus and rituximab in patients with relapsed or refractory mantle cell lymphoma: a phase 2 study
Stephen M. Ansell et al.
LANCET ONCOLOGY (2011)
A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers
Siwanon Jirawatnotai et al.
NATURE (2011)
DNA REPAIR Cyclin D1 multitasks
Jiri Bartek et al.
NATURE (2011)
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
Xose S. Puente et al.
NATURE (2011)
Epigenetic Activation of SOX11 in Lymphoid Neoplasms by Histone Modifications
Maria Carmela Vegliante et al.
PLOS ONE (2011)
A cyclin-D1 interaction with BAX underlies its oncogenic role and potential as a therapeutic target in mantle cell lymphoma
Elena Beltran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
New molecular targets in mantle cell lymphoma
Samir Parekh et al.
SEMINARS IN CANCER BIOLOGY (2011)
The complex landscape of genetic alterations in mantle cell lymphoma
Cristina Royo et al.
SEMINARS IN CANCER BIOLOGY (2011)
The microenvironment in mantle cell lymphoma: Cellular and molecular pathways and emerging targeted therapies
Jan A. Burger et al.
SEMINARS IN CANCER BIOLOGY (2011)
Therapy of Mantle Cell Lymphoma: New Treatment Options in an Old Disease or Vice Versa?
Martin Dreyling
SEMINARS IN HEMATOLOGY (2011)
Interleukin 22 Signaling Promotes Cell Growth in Mantle Cell Lymphoma
Pascal Gelebart et al.
TRANSLATIONAL ONCOLOGY (2011)
Phospho-proteomic analysis of mantle cell lymphoma cells suggests a pro-survival role of B-cell receptor signaling
Chiara Pighi et al.
CELLULAR ONCOLOGY (2011)
Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia
Jonathan W. Friedberg et al.
BLOOD (2010)
The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo
Victoria J. Weston et al.
BLOOD (2010)
Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling
Elena M. Hartmann et al.
BLOOD (2010)
Nuclear Cyclin D1/CDK4 Kinase Regulates CUL4 Expression and Triggers Neoplastic Growth via Activation of the PRMT5 Methyltransferase
Priya Aggarwal et al.
CANCER CELL (2010)
Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma
Veronica Fernandez et al.
CANCER RESEARCH (2010)
Constitutive and B-cell receptor-induced activation of STAT3 are important signaling pathways targeted by bortezomib in leukemic mantle cell lymphoma
Fanny Baran-Marszak et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Mantle Cell Lymphoma 12 Years After Allogeneic Bone Marrow Transplantation Occurring Simultaneously in Recipient and Donor
Beth Christian et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Cytostatic and anti-angiogenic effects of temsirolimus in refractory mantle cell lymphoma
Li Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2010)
ATM Deficiency Sensitizes Mantle Cell Lymphoma Cells to Poly(ADP-Ribose) Polymerase-1 Inhibitors
Chris T. Williamson et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity
Wyndham H. Wilson et al.
LANCET ONCOLOGY (2010)
Transcriptional role of cyclin D1 in development revealed by a genetic-proteomic screen
Frederic Bienvenu et al.
NATURE (2010)
mToR signaling and drug development in cancer
Janet Dancey
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling
Silvia Bea et al.
BLOOD (2009)
TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas
Keiichiro Honma et al.
BLOOD (2009)
Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA-4 (CD49d): importance for interactions with the stromal microenvironment and specific targeting
Antonina V. Kurtova et al.
BLOOD (2009)
Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B-cell lymphoma entities
Anja Mottok et al.
BLOOD (2009)
MicroRNA Expression, Chromosomal Alterations, and Immunoglobulin Variable Heavy Chain Hypermutations in Mantle Cell Lymphomas
Alba Navarro et al.
CANCER RESEARCH (2009)
Bcl-2 inhibitors: small molecules with a big impact on cancer therapy
M. Vogler et al.
CELL DEATH AND DIFFERENTIATION (2009)
Phosphatidylinositol 3′-Kinase Catalytic Subunit α Gene Amplification Contributes to the Pathogenesis of Mantle Cell Lymphoma
Amanda Psyrri et al.
CLINICAL CANCER RESEARCH (2009)
SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype
Ana Mozos et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Time to Treatment Does Not Influence Overall Survival in Newly Diagnosed Mantle-Cell Lymphoma
Heather E. Eve et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Outcome of Deferred Initial Therapy in Mantle-Cell Lymphoma
Peter Martin et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase III Study to Evaluate Temsirolimus Compared With Investigator's Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
Georg Hess et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
t(11;14)-positive clones can persist over a long period of time in the peripheral blood of healthy individuals
Y. Lecluse et al.
LEUKEMIA (2009)
Temsirolimus for the treatment of mantle cell lymphoma
Georg Hess
EXPERT REVIEW OF HEMATOLOGY (2009)
Therapeutic Targeting of NOTCH1 Signaling in T-Cell Acute Lymphoblastic Leukemia
Teresa Palomero et al.
CLINICAL LYMPHOMA & MYELOMA (2009)
Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma
Pascal Gelebart et al.
BLOOD (2008)
Distinct functional significance of Akt and mTOR constitutive activation in mantle cell lymphoma
Jessica Dal Col et al.
BLOOD (2008)
Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma
Robert W. Chen et al.
BLOOD (2008)
Nuclear expression of the non-B-cell lineage Sox 11 transcription factor identifies mantle cell lymphoma
Sara Ek et al.
BLOOD (2008)
The BH3-only mimetic ABT-737 synergizes the antineoplastic activity of proteasome inhibitors in lymphoid malignancies
Luca Paoluzzi et al.
BLOOD (2008)
Advances in the understanding of mantle cell lymphoma
Pedro Jares et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Low-dose, single-agent temsirolimus for relapsed mantle cell lymphoma - A phase 2 trial in the North Central Cancer Treatment Group
Stephen M. Ansell et al.
CANCER (2008)
A novel paradigm for rapid ABT-737-induced apoptosis involving outer mitochondrial membrane rupture in primary leukemia and lymphoma cells
M. Vogler et al.
CELL DEATH AND DIFFERENTIATION (2008)
A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malignancies
David A. Rizzieri et al.
CLINICAL CANCER RESEARCH (2008)
Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics
Pedro Jares et al.
NATURE REVIEWS CANCER (2007)
Bortezomib for the treatment of mantle cell lymphoma
Robert C. Kane et al.
CLINICAL CANCER RESEARCH (2007)
Inactivation of RB1 in mantle-cell lymphoma detected by nonsense-mediated mRNA decay pathway inhibition and microarray analysis
Magda Pinyol et al.
BLOOD (2007)
The BH3-mimetic GX15-070 synergizes with bortezomib in mantle cell lymphoma by enhancing Noxa-mediated activation of Bak
Patricia Perez-Galan et al.
BLOOD (2007)
A novel human B cell subpopulation representing the initial germinal center population to express AID
Grant R. Kolar et al.
BLOOD (2007)
Selective inhibition of IκB kinase sensitizes mantle cell lymphoma B cells to TRAIL by decreasing cellular FLIP level
Gael Roue et al.
JOURNAL OF IMMUNOLOGY (2007)
Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival
Adrian Wiestner et al.
BLOOD (2007)
The heat shock protein 90 inhibitor 17-AAG induces cell cycle arrest and apoptosis in mantle cell lymphoma cell lines by depleting cyclin D1, Akt, Bid and activating caspase 9
Georgios V. Georgakis et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma
Martina Rudelius et al.
BLOOD (2006)
A chromosomal translocation in cyclin D1-negative/cyclin D2-positive mantle cell lymphoma fuses the CCND2 gene to the IGK locus
Stefan Gesk et al.
BLOOD (2006)
Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma
TC Greiner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma
A Rinaldi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status
P Perez-Galan et al.
BLOOD (2006)
Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL):: a clinicopathological study from the European MCL Network
M Tiemann et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Phase II trial of single-agent temsirolimus (CCI-779) for relapsed mantle cell lymphoma
TE Witzig et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGFβ signalling pathways
EG Rizzatti et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Identification and characterization of circulating human transitional B cells
GP Sims et al.
BLOOD (2005)
CDK4 and MDM2 gene alterations mainly occur in highly proliferative and aggressive mantle cell lymphomas with wild-type INK4a/ARF locus
L Hernández et al.
CANCER RESEARCH (2005)
Minireview: Cyclin D1: Normal and abnormal functions
MF Fu et al.
ENDOCRINOLOGY (2004)
VH mutation status and VDJ rearrangement structure in mantle cell lymphoma:: correlation with genomic aberrations, clinical characteristics, and outcome
D Kienle et al.
BLOOD (2003)
Inhibition of constitutive NF-κB activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis
LV Pham et al.
JOURNAL OF IMMUNOLOGY (2003)
A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease
J Orchard et al.
BLOOD (2003)
Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma
SH Walsh et al.
BLOOD (2003)
Flavopiridol in untreated or relapsed mantle-cell lymphoma: Results of a phase II study of the National Cancer Institute of Canada clinical trials group
CT Kouroukis et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma
A Rosenwald et al.
CANCER CELL (2003)
Expression of STAT3 and its phosphorylated forms in mantle cell lymphoma cell lines and tumours
R Lai et al.
JOURNAL OF PATHOLOGY (2003)
Phase II study of oral vinorelbine in first-line advanced breast cancer chemotherapy
G Freyer et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances
E Camacho et al.
BLOOD (2002)
The splenic form of mantle cell lymphoma
MK Angelopoulou et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2002)
Mantle cell lymphoma proliferates upon IL-10 in the CD40 system
HPJ Visser et al.
LEUKEMIA (2000)
分享论文
